Nicolas Kolar-Gaboriaud
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Biomimetic Synthesis of Oleocanthal, Oleacein, and Their Analogues Starting from Oleuropein, A Major Compound of Olive Leaves.
Journal: Journal of natural products
Published: May 23, 2020
Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
Journal: Virulence
Published: November 03, 2018
Indirubin Analogues Inhibit Trypanosoma brucei Glycogen Synthase Kinase 3 Short and T. brucei Growth.
Journal: Antimicrobial agents and chemotherapy
Published: September 27, 2018
The Indirubin Derivative 6-Bromoindirubin-3'-Oxime Activates Proteostatic Modules, Reprograms Cellular Bioenergetic Pathways, and Exerts Antiaging Effects.
Journal: Antioxidants & redox signaling
Published: March 04, 2017
Evaluation of Dual 5-Lipoxygenase/Microsomal Prostaglandin E2 Synthase-1 Inhibitory Effect of Natural and Synthetic Acronychia-Type Isoprenylated Acetophenones.
Journal: Journal of natural products
Published: February 28, 2017
New semi-synthetic analogs of oleuropein show improved anticancer activity in vitro and in vivo.
Journal: European journal of medicinal chemistry
Published: February 27, 2017
6-bromo-indirubin-3'-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts.
Journal: Scientific reports
Published: December 29, 2016
Natural-Based Indirubins Display Potent Cytotoxicity toward Wild-Type and T315I-Resistant Leukemia Cell Lines.
Journal: Journal of natural products
Published: October 12, 2016
Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis.
Journal: Journal of medicinal chemistry
Published: September 13, 2016
From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.
Journal: Antimicrobial agents and chemotherapy
Published: January 05, 2016
Indirubin derivatives: a patent review (2010 - present).
Journal: Expert opinion on therapeutic patents
Published: April 19, 2015
Last Updated: 09/26/2026